DANBURY, CONN. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
IQVIA™ (NYSE:IQV) today announced that Ferring Pharmaceuticals, a global leader in reproductive health, women’s health and other medical therapies, has selected IQVIA Technologies’ Orchestrated Customer Engagement (OCE) platform for global deployment across more than 50 markets.
“We are pleased to be working with IQVIA on this project,” said Vincent Turgis, Global CIO, Ferring Pharmaceuticals. “OCE will enable us to streamline processes while developing strong customer relationships as we better anticipate and respond to market changes.”
IQVIA Technologies’ OCE for advanced customer engagement breaks down silos by seamlessly connecting sales, account management, and other functions to enhance the customer experience, strengthen relationships, and drive performance. OCE is built on best-in-class industry platforms, including Salesforce, Amazon Web Services, MuleSoft, Heroku, and Box. With unique capabilities, such as predictive analytics and machine learning, OCE provides an intuitive consumer-grade user experience, AI-enabled recommendations, seamless integration with other data and applications to drive better decision-making.
“We are confident that OCE will transform Ferring’s customer interactions by optimizing performance,” said Tal Rosenberg, senior vice president, Global Technology Solutions for IQVIA Technologies. “OCE is part of an integrated commercial ecosystem that enables clients to manage the process of customer engagement from one end to the other. This platform will harmonize customer interactions, which leads to enhanced trust and optimized performance with clients.”
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With more than 58,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
Copyright Business Wire 2019